Intellia Therapeutics Overview
Intellia Therapeutics Discounted Cash Flow
DCF Analysis for NTLA.
Get informed when a big investor buys or sells
+ FollowFair Value
$0.57
Current Fair Value
$0.57
↓ 96.2% Downside
Overvalued by 96.2% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison